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SUMMARY
The intestinal epithelium serves as an essential barrier to the outside world and is maintained by functionally distinct populations of
rapidly cycling intestinal stem cells (CBC ISCs) and slowly cycling, reserve ISCs (r-ISCs). Because disruptions in the epithelial barrier
can result from pathological activation of the immune system, we sought to investigate the impact of inflammation on ISC behavior
during the regenerative response. In a murine model of aCD3 antibody-induced small-intestinal inflammation, r-ISCs proved highly
resistant to injury, while CBC ISCs underwent apoptosis. Moreover, r-ISCs were induced to proliferate and functionally contribute to in-
testinal regeneration. Further analysis revealed that the inflammatory cytokines interferon gamma and tumor necrosis factor alpha led to
r-ISC activation in enteroid culture, which could be blocked by the JAK/STAT inhibitor, tofacitinib. These results highlight an important
role for r-ISCs in response to acute intestinal inflammation and show that JAK/STAT-1 signaling is required for the r-ISC regenerative
response.
INTRODUCTION
The intestinal epithelium is a rapidly self-renewing tissue
that plays an essential role in maintaining the balance be-
tween selective absorption and maintenance of barrier
function. This balance is fundamentally disrupted in con-
ditions such as inflammatory bowel disease (IBD), where
immune dysregulation leads to breakdown of the epithelial
barrier yielding mucosal ulcerations, malabsorption, and
chronic systemic illness. While current efforts are focused
on modulating the immune dysregulation inherent to
IBD, themechanisms underlying epithelial repair and resti-
tution remain understudied and may lend insight into
alternative approaches to the treatment of IBD.
The histopathologic feature of crypt branching, seen in
IBD, results from crypt fission in response to crypt loss,
and is likely associated with activation of intestinal stem
cells (ISCs) and progenitor cells in the crypt (Jevon and
Madhur, 2010). Two functionally distinct populations of
ISCs are responsible for maintaining the epithelium:
rapidly cycling crypt base columnar (CBC) ISCs, marked
by Lgr5 (Barker et al., 2007), and slowly cycling, reserve
stem cells (r-ISCs) located in the ‘‘+4’’ supra-Paneth cell po-
sition andmarked by telomerase (mTert) and other markers
(Gracz et al., 2010; Montgomery et al., 2011; Takeda et al.,
2011). Although CBC ISCs play an important role in daily
intestinal maintenance, they are highly sensitive to injury,
whereas r-ISCs are highly resistant to injury and contribute
to the intestinal lineage during regeneration (Goodell et al.,
2015; Richmond et al., 2015). What role r-ISCs play in
response to inflammatory insults and what factors regulate
their response have not yet been explored.
The role of cytokines and their downstream signaling
pathways in the pathophysiology of IBD has been well
studiedwith a primary focus on their regulation of immune
function (Wittkopf et al., 2014). The JAK/STAT signaling
pathway has been implicated in the regulation of the im-
mune inflammatory response (Neurath, 2014; Wittkopf
et al., 2014) and is activated in response to interferon-g
(IFN-g) and tumor necrosis factor alpha (TNF-a), two key
downstream inflammatory mediators of IBD pathogenesis.
Whether this pathway also regulates the ISC response to
inflammation, and thus epithelial regeneration following
injury, remains unknown. Here, we report that in response
to acute intestinal inflammation, r-ISCs are activated to
enter the cell cycle, undergo JAK/STAT-1 activation, and
functionally contribute to epithelial restitution.
RESULTS
Anti-CD3 Antibody Treatment Leads to Intestinal
Injury Followed by Rapid Recovery
To investigate how ISCs respond to inflammation, we uti-
lized a previously established model of T cell-mediated
small-intestinal inflammation induced by administration
of anti-CD3 antibody (aCD3) (Ferran et al., 1990). aCD3
leads to T cell activation, which results in an acute,
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Figure 1. aCD3 Leads to Epithelial Injury and CBC Loss with Subsequent Recovery
(A) Representative H&E images of small intestine at baseline, injury, early recovery, and late recovery. Scale bar, 100 mm.
(B) Villus height and crypt depth (mm) following aCD3 compared with baseline. N = 2 mice/time point, 30/19, 83/83, 94/94, 147/147 total
villus/crypt measurements counted.
(legend continued on next page)
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self-limited ‘‘cytokine release syndrome’’ (CRS) of fever,
enteritis, and diarrhea similar to an acute flare of IBD
(Ferran et al., 1990). CRS is also associated with histomor-
phometric changes consisting of villus shortening, crypt
degeneration, and cell death, mimicking IBD-associated
small-intestinal pathology (Radojevic et al., 1999). Adult
mice received a single intraperitoneal injection of aCD3
and the proximal small intestines were examined at base-
line (day 0), peak injury (day 2), early (day 4), and late
(day 6–7) recovery. Consistent with findings from other
groups (Radojevic et al., 1999), we observedmoderate to se-
vere histological abnormalities at the peak of injury, with
near normalization of histology by late recovery, under-
scoring the enormous regenerative capacity of this tissue
(Figure 1A). Compared with baseline, mice treated with
aCD3 showed decreased villus height and body weight at
the peak of injury, followed by expansion of the crypt
compartment during early recovery, and near resolution
by the late recovery phase (Figures 1A, 1B, S1A, and S1B).
The expansion of the crypt compartment, where ISCs
reside, raised the possibility that ISCs sensed intestinal
damage and initiated a regenerative response.
R-ISCs Are Resistant to Inflammation-Induced
Apoptosis
Given the tissue damage caused by aCD3 (Figure 1A,
injury), we anticipated a general increase in crypt cell death
at the peak of injury. Using cleaved caspase-3 (CC3) as a
marker for apoptosis, we analyzed the number of CC3+
crypt cells at various time points during the 7-day experi-
ment. As anticipated, evaluation of more than 10,000
crypts showed that the overall number of CC3+ crypt
cells increased 9-fold at the peak of injury (48 hr) with a
subsequent gradual return to baseline levels (Figures 1C,
S1C, and S1E). These findings were then independently
confirmed by TUNEL staining (Figures 1D, S1D, and S1F).
To analyze the rate of ISC apoptosis at the peak of injury,
we utilized the previously validated mTert-GFP mouse
model, as a reporter of r-ISCs (Breault et al., 2008), and
the Lgr5-GFP mouse model, as a reporter of CBC ISCs
(Barker et al., 2007). We scored small-intestinal crypt sec-
tions co-stained for GFP and CC3 from mice treated with
either aCD3 antibody or isotype control IgG. Unsurpris-
ingly, given the level of epithelial damage (Figure 1A,
injury), immunofluorescent analysis of CBC ISCs at the
peak of injury showed a dramatic increase in the number
of co-positive Lgr5-GFP+ CC3+ cells (from 0.7% to 16%), a
22-fold increase compared with controls (Figure S1G).
These findings were confirmed using flow cytometric anal-
ysis of CC3 at the same time point, which showed that
60% of CBC ISCs were CC3+, underscoring their vulnera-
bility to inflammatory injury (Figure 1E). In contrast, anal-
ysis of CC3 in r-ISCs at the peak of injury revealed no
apoptosis (0 of 39 mTert-GFP+ cells) by immunofluores-
cence and no change in the number of mTert-GFP+ CC3+
co-positive cells by flow cytometric analysis (Figure 1F),
indicating that these cells are resistant to inflammation-
induced injury. Consistent with the above, there was a
significant decrease in the number of surviving Lgr5hi
ISCs (Figures 1G and S1H) while the number of viable
mTert r-ISCs showed a modest increase following aCD3
treatment (Figures 1H and S1I). Together, these data
demonstrate that r-ISCs are highly resistant to inflamma-
tion while CBC ISCs are highly sensitive and underscore
the differential response of the two ISC populations to
intestinal injury.
R-ISCs Are Activated to Enter the Cell Cycle in
Response to Inflammation
Previously, our lab and others have shown that r-ISCs func-
tion as a reserve stem cell population that can be activated
in response to intestinal damage (Richmond et al., 2015;
Tian et al., 2011). Therefore, we next examined whether
mTert-GFP+ r-ISCs were activated in response to aCD3-
induced intestinal injury. Analysis of crypt sections re-
vealed a significant increase (2.3-fold) in the number of
mTert-GFP+ cells during the early recovery phase compared
with baseline (Figure 2A), suggesting a possible role for
these cells in the recovery following inflammatory damage.
We next investigated if the increase in mTert-GFP+ cell
number was due to enhanced proliferation within this nor-
mally quiescent population (Breault et al., 2008). Immuno-
fluorescent analysis of intestinal crypt sections revealed
that 30% of mTert-GFP+ cells in aCD3-treated mice were
Ki67+ (a marker of proliferation) at the early stage of recov-
ery, compared with only 2% in controls (Figures 2B and
S2A). A similar increase in proliferation was observed in
mTert-GFP mice administered ethynyl deoxyuridine (EdU)
(C) Crypt cells expressing cleaved caspase-3 (CC3) at baseline (N = 20) and injury (N = 9).
(D) Crypt cells expressing TUNEL at baseline (N = 4) and injury (N = 7).
(E) Lgr5-GFP+CC3+CD45PI cells 48 hr after control IgG (N = 3) and aCD3 (N = 3).
(F) mTert-GFP+CC3+CD45PI cells 48 hr after control IgG (N = 3) or aCD3 (N = 3).
(G) Live Lgr5-GFPhi cells 48 hr after control IgG (N = 3) or aCD3 (N = 3).
(H) Live mTert-GFP cells 48 hr after control IgG (N = 3) or aCD3 (N = 3).
Error bars indicate the SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s., not significant. Representative flow cytometry plots
shown.
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on day 3 following aCD3 treatment and then analyzed by
3D whole-mount crypt analysis on day 4. Analysis of 388
mTert-GFP+ cells from 800 isolated crypts showed a signifi-
cant increase in the number (3% /14%) of mTert-GFP+
EdU+ co-positive cells between control and aCD3-treated
mice (Figures 2C and S2B). A more limited increase in
cycling frequency was seen in the CBC ISC compartment
during early recovery (Figure S2C), likely representing
increased proliferation in cells that survived the inflamma-
tion or in those already replenished by the activated r-ISC
population (Montgomery et al., 2011). Taken together,
these data show that the marked increase in mTert-GFP+
cells occurs through enhanced proliferation during the
early recovery period in response to the inflammatory
milieu.
Activated r-ISCs Contribute to Intestinal Regeneration
Following Inflammation
To functionally assess whether r-ISCs that were acti-
vated in response to inflammation had the capacity to
contribute to intestinal regeneration during the recovery
phase, we performed lineage-tracing studies. For these ex-
periments, we employed the previously validated tamox-
ifen-inducible mTert-CreER::R26R(LacZ) bigenic mouse
model to mark r-ISCs (Montgomery et al., 2011). To
ensure concordant expression of this model with mice
expressing the mTert-GFP allele, we generated enteroids
from trigenic mTert-GFP::mTert-CreER::R26R(LacZ) mice.
Flow cytometric analysis of these enteroids revealed that
the majority of LacZ+ cells co-expressed GFP, confirming
that the two mouse models label the same cell population
A
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Figure 2. R-ISC Numbers Increase and
Enter the Cell Cycle following aCD3
(A) mTert-GFP+ crypt cells per 150 crypt sec-
tions at baseline, injury, early recovery, and
late recovery. N = 2 mice/time point, 18, 21,
20, and 9 sections counted.
(B) mTert-GFP+ crypt cells co-expressing Ki67
in control IgG and aCD3-treated mice at early
recovery. Representative optical sections
from control IgG- (N = 8) and aCD3-treated
(N = 4) mice showing cycling (arrowhead) and
quiescent (arrow) mTert-GFP+ cells in merged,
DAPI, mTert-GFP, and Ki67 channels.
(C) mTert-GFP+ cells co-expressing EdU in
isolated crypts from control IgG- (N = 3) and
aCD3-treated (N = 3) mice at early recovery.
Representative optical sections showing
quiescent mTert-GFP+ cells (arrow) in control
IgG and cycling mTert-GFP+ cells in aCD3-
treated (arrowhead) crypts in merged DAPI,
mTert-GFP, and EdU (Click-iT) channels.
Error bars indicate the SEM. *p < 0.05, **p <
0.01, ***p < 0.001, ****p < 0.0001. Scale
bar, 10 mm.
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(Figures S3A and S3B). Further analysis additionally
confirmed a 6-fold enrichment of Cre expression in
GFP+ cells isolated by fluorescence-activated cell sorting
compared with GFP cells (Figure S3C). Lgr5-CreER::
R26R(LacZ) bigenic mice were used to assess the response
of CBC ISCs (Barker et al., 2007). Mice received either
aCD3 or IgG at the initiation of the experiment followed
by a single dose of tamoxifen at the peak of injury (day 2).
Intestines were then harvested either 1 day later (day 3) to
elucidate the immediate ISC response, or at the late recov-
ery time point (day 7) to elucidate their regenerative
contribution, and analyzed by quantitative whole-mount
LacZ staining. When analyzed 1 day following the peak of
injury, Lgr5-CreER::R26R(LacZ) mice revealed an 11-fold
decrease in the total number of Lgr5-LacZ-marked crypts
(Figure 3A), consistent with their increased rate of
apoptosis in response to injury (Figures 1E and S1G).
Analysis of mTert-CreER::R26R(LacZ) mice killed on day
3 showed no significant change in overall LacZ crypt la-
beling although there was a trend toward an increase at
this early time point (Figure S3D). Analysis at the late re-
covery time point however revealed a 6-fold increase in
the total number of mTert-LacZ-marked crypts (Figure 3B),
highlighting their robust response to this regenerative
pressure. Further analysis revealed that, after aCD3 treat-
ment, the majority of these mTert-LacZ-labeled crypts con-
tained multiple lineage-marked cells (Figure 3C), consis-
tent with the increase in r-ISC proliferation observed
above (Figures 2B and 2C). By the late recovery time
point, the number of Lgr5-LacZ-marked crypts had re-
bounded to control levels (Figure S3E), suggesting that
CBC ISCs also support the regenerative recovery once
their population is replenished. Taken together, these
data confirm that r-ISCs, activated in response to inflam-
matory injury, contribute to the regenerative response,
followed by a secondary wave of CBC ISC activation to
support full epithelial restitution.
Finally, to rule out that the increase in labeled crypt cells
did not result from activation of themTert promoter,mTert-
CreER::R26R(LacZ) mice were pre-treated with tamoxifen
to mark the r-ISC population during a non-inflamed base-
line state. Because of its long biological half-life (Robinson
et al., 1991), tamoxifenwas allowed towash out for 10 days
before mice were administered either aCD3 or IgG, and
intestines were analyzed 4 days later, during the early re-
covery phase. Quantitative whole-mount LacZ analysis
revealed an increase (11-fold) in the number of crypts
containing multiple LacZ+ cells (Figure S3F), likely due to
division of cells labeled prior to injury and consistent
with activation of the reserve ISC population. These results
support our above findings that r-ISCs are activated to
enter the cell cycle in response to inflammation and
contribute to the regenerative response.
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Figure 3. R-ISCs Show Increased Lineage Contribution
Following aCD3 while the CBC Contribution Is Reduced
(A) Quantitative whole-mount analysis showing a decrease in the
number of lineage-marked LacZ+ crypts from Lgr5-Cre::R26R(LacZ)
IgG- (N = 4) and aCD3-treated (N = 4) mice at injury. Represen-
tative whole mounts of b-gal+ crypts.
(B) Quantitative whole-mount analysis showing increase in the
number of lineage-marked LacZ+ crypts from mTert-Cre::R26R(LacZ)
IgG- (N = 9) and aCD3-treated (N = 10) mice during late recovery.
Representative whole mounts of b-gal+ crypts.
(C) Change in distribution of crypts with single and multiple mTert-
LacZ+ cells 7 days after IgG (N = 9 mice) or aCD3 (N = 10 mice)
indicating an increase in the number of crypts with multiple cells
following aCD3 treatment.
Error bars indicate the SEM. *p < 0.05, **p < 0.01. Scale bar, 1 mm.
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Interferon-g and Tumor Necrosis Factor Alpha
Activate r-ISCs In Vitro
The primary cytokines released in response to aCD3
administration include IFN-g and TNF-a, important medi-
ators of IBD in humans (Ferran et al., 1991; Musch et al.,
2002). To investigate whether these cytokines mediated
the inflammation-induced activation of r-ISCs, we turned
to the enteroid culture system (Sato et al., 2009). Initially,
we confirmed that enteroids could respond to exogenous
cytokine treatment. Mature enteroids were treated with
IFN-g (5 ng/mL) or vehicle and assayed for induction of
downstream target genes (Irf1, Stat-1, Nfkb, and Ccnd1)
(Cheon and Stark, 2009; Rauch et al., 2013). qRT-PCR anal-
ysis revealed robust induction of each genewithin 4 hr (Fig-
ure S4A), indicating that enteroids can respond to exoge-
nous cytokine stimulation. We then derived enteroids
from mTert-GFP mice and cultured them in the presence
of IFN-g or vehicle (PBS). Flow cytometric analysis after
48 hr of treatment revealed a 2-fold increase in GFP+ cells
following IFN-g treatment compared with vehicle-treated
controls (Figure 4A). In contrast, enteroids derived from
Lgr5-GFP mice revealed a 67% decrease in Lgr5-GFPhi+ cells
following IFN-g treatment (Figure 4B). We also examined
the effect of TNF-a (50 ng/mL) onmTert-GFP-derived enter-
oids and observed a similar increase in mTert-GFP+ cells
(Figure S4B). The increase in mTert-GFP+ r-ISC cells in
response to both IFN-g and TNF-a, the twomajor cytokines
involved in the aCD3-induced cytokine storm and in
human IBD, suggests that activation of r-ISCs in vivo may
result from direct immune-epithelial cell crosstalk.
JAK/STAT-1 Pathway Activates r-ISCs in Response to
Inflammation
Since IFN-g and TNF-a are known to mediate their effects
through JAK/STAT signaling (Li, 2008; Rauch et al., 2013),
we next investigated the role of this pathway in vivo, using
intestinal crypt sections from mice at early and late recov-
ery time points following aCD3 or IgG administration.
Immunofluorescent analysis for the active form of
STAT-1, phospho-STAT-1 (pSTAT-1), revealed no significant
change in the total number of pSTAT-1+ crypt cells (Fig-
ure S4C). However, specific analysis of mTert-GFP+ cells re-
vealed a dramatic increase in the percentage ofmTert-GFP+
pSTAT-1+ co-labeled cells during the early recovery time
point, which returned to baseline levels by the late recov-
ery time point (Figures 4C and S4D). In contrast, analysis
of co-expression of mTert-GFP+ cells with either pSTAT-5
or pSTAT-3, both previously suggested to play a role in
the intestinal epithelial response to inflammation (Linde-
mans et al., 2015;Matthews et al., 2011), revealed amarked
decrease in pSTAT-5 co-expression at the early recovery
time point (Figure S4E), and no mTert-GFP+ cells (0 of
181) that co-expressed pSTAT-3. In addition, no significant
changes in pSTAT-1 co-expression were detected in CBC
ISCs in vivo (Figure S4F), reinforcing the differential mech-
anisms involved in the response of r-ISCs and CBC ISCs
to inflammation. These data indicate that JAK/STAT-1
signaling is activated by inflammation during the r-ISC
regenerative response.
Finally, to investigate if JAK/STAT-1 signaling was
required for the activation of r-ISCs during inflammation,
we pre-treated enteroid cultures derived from mTert-GFP
mice with tofacitinib (TOFA), a pan-JAK/STAT inhibitor,
recently approved by the US Food and Drug Administra-
tion for the treatment of ulcerative colitis (Sandborn
et al., 2014), prior to administration of IFN-g. Inhibition
of JAK/STAT signaling with TOFA completely blocked
the IFN-g-driven induction in r-ISC number otherwise
seen after treatment, yielding comparable numbers as
vehicle-treated controls (Figure 4D). Taken together, these
data indicate that JAK/STAT-1 signaling activates r-ISCs
following inflammatory injury and underlies their regener-
ative response.
DISCUSSION
Here, we report the results of in vitro and in vivo analyses
examining the effects of inflammation on reserve and
CBC ISCs, including their relative contribution to intesti-
nal regeneration. Our findings show that small-intestinal
inflammation induced by aCD3 leads to (1) marked tissue
damage associated with an increase in apoptosis in CBC
ISCs but not r-ISCs, (2) an increase in r-ISC number result-
ing from their activation to enter the cell cycle, (3) an in-
crease in r-ISC lineage contribution during the regenerative
response, and (4) activation of JAK/STAT-1 signalingwithin
r-ISCs. These results are in contrast to the response of CBC
ISCs, which show a reduced regenerative capacity immedi-
ately following the injury. This differential response is
further substantiated by an increasing body of literature
supporting the notion that pathways important for regula-
tion of ISCs in response to tissue injury, both in mammals
and Drosophila, are distinct from those that regulate tissue
maintenance (Biteau et al., 2011).
Our findings confirm previously reported structural
changes in the small intestine following aCD3 treatment,
including a reduction in villus height followed by an in-
crease in the average crypt depth. Utilizing the major cyto-
kines (IFN-g, TNF-a) released during aCD3 treatment in vivo
(Ferran et al., 1990), we developed an in vitro system to
model the epithelial response to inflammation. This model
showed an increase in the number of r-ISCs in response to
these cytokines, providing a potential link between im-
mune cells and epithelial stem cells. Our in vitro analysis
also revealed activation of the canonical JAK/STAT-1
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signaling pathway. To confirm this in vivo, we per-
formed co-immunofluorescent analysis, which revealed
that STAT-1 is the dominant pathway in r-ISCs. Given
that both IFN-g and TNF-a are traditionally considered
to be ‘‘pro-inflammatory’’ cytokines that have a negative
impact on intestinal function (Luissint et al., 2016), these
data raise the possibility that specific cytokine signaling
pathways may have differential effects on the epithelium
in general, and on ISCs in particular.
Consistent with the above observation, although IFN-g is
generally considered to disrupt the intestinal epithelial bar-
rier by blocking intestinal epithelial cell (IEC) proliferation
A
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Figure 4. Cytokines Induce R-ISCs via
JAK/STAT-1
(A) Live mTert-GFP+ cells from vehicle (PBS)-
and IFN-g-treated enteroid cultures after
48 hr. Representative images of mTert-GFP
enteroid cultures 48 hr after vehicle or IFN-g.
Arrows identify mTert-GFP+ cells. Enteroid
lines derived from N = 3 mice. Scale bar,
50 mm.
(B) Live Lgr5-GFPhi cells from vehicle and IFN-
g-treated enteroid cultures after 48 hr.
Representative images of Lgr5-GFP enteroid
cultures 48 hr after vehicle or IFN-g. Arrows
identify Lgr5-GFP+ cells. Enteroid lines derived
from N = 3 mice. Scale bar, 50 mm.
(C) mTert-GFP+ crypt cells that co-express
pSTAT-1 at baseline (N = 7 mice), early
recovery (N = 4 mice), and late recovery
(N = 3 mice). Representative optical sections
showing an mTert-GFP+ pSTAT-1 cell (arrow)
in IgG-treated and an mTert-GFP+ pSTAT-1+
cell (arrowhead) in aCD3-treated mice at early
recovery in DAPI, mTert-GFP, and pSTAT-1
merged channels. Scale bar, 10 mm.
(D) Fold change in mTert-GFP+ enteroid cells
following treatment with vehicle, JAK/STAT-1
inhibitor tofacitinib (TOFA) only, IFN-g only,
and IFN-g + TOFA. Enteroid lines derived from
N = 3 mice.
Error bars indicate the SEM. **p < 0.01,
***p < 0.001, ****p < 0.0001.
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and increasing IEC apoptosis (Beaurepaire et al., 2009; Gor-
etsky et al., 2012), it hasmore recently been reported to also
support intestinal barrier function by stimulating the
expression of interleukin-10 receptor on IECs (Kominsky
et al., 2014). IFN-g has also been found to attenuate tissue
damage via upregulation of matrix metalloproteinases (Ma
et al., 2001), modulation of prostaglandin E2 metabolism
(Barrios-Rodiles and Chadee, 1998), and reduction in
lymphocyte infiltration (Vermeire et al., 1997), all suggest-
ing that itmay have diverse and even paradoxical effects on
distinct cell populations within the epithelium.
The epithelium can also produce cytokines itself
that support wound healing after injury (Stadnyk, 1994).
In Drosophila, stressed IECs produce cytokines, which can
activate pro-mitogenic JAK/STAT signaling in an auto-
crine/paracrine fashion (Jiang et al., 2009; Zhou et al.,
2013). Following tissue injury inmammals and in response
to local cytokine production, IECs lose their cellular polar-
ity and migrate to cover the wound in an attempt to main-
tain intestinal barrier function (Neurath, 2014; Sturm and
Dignass, 2008). Termed ‘‘epithelial restitution,’’ this pro-
cess is regulated by cytokines (Dignass and Podolsky,
1993; Neurath, 2014) and is increasingly recognized as a
critical component of mucosal healing following a flare
of IBD. This process is driven by the proliferative crypt
compartment and is tightly regulated (Neurath, 2014).
Although STAT-3 and STAT-5 signaling have both been
implicated in supporting wound healing, both in general
and in CBC ISCs in particular (Gilbert et al., 2015; Linde-
mans et al., 2015), our work supports an important role
for STAT-1 signaling in regulating the regenerative response
of r-ISCs.
Although often associated with negative regulation of
cell-cycle genes (Chin et al., 1996) and positive regulation
of cleaved caspase-3 (Kumar et al., 1997), in this study,
STAT-1 activation in r-ISCs was associated with entry into
the cell cycle and prevention of apoptosis in response to
inflammation. STAT-1 signaling is also required for produc-
tion of nitric oxide during inflammation (Stempelj et al.,
2007), andmay, therefore, mediate IEC survival by helping
to maintain mucosal integrity (McCafferty et al., 1997).
In addition, JAK/STAT signaling positively regulates the
Notch signaling pathway in ISCs, potentially facilitating
the inter-conversion between r-ISCs andCBC ISCs and sub-
sequent restitution of the CBC ISC population following
tissue injury, thereby supporting epithelial wound healing
(Pitsouli et al., 2009; Srinivasan et al., 2016).
Taken together, our results demonstrate that, in response
to acute inflammation induced by aCD3, r-ISCs are acti-
vated to proliferate and functionally contribute to the sub-
sequent regenerative response when CBC ISCs are initially
lost or damaged. Mechanistically, this response requires, at
least in part, the induction of JAK/STAT-1 signaling specif-
ically within r-ISCs. This work raises important questions
regarding how best to target inflammatory signaling path-
ways in order to optimally support the r-ISC regenerative
response.
EXPERIMENTAL PROCEDURES
Detailed methods are available in Supplemental Information.
Statistical Analysis
Two-tailed Student’s t test was used to compare groups of two- and
one-way ANOVA with Bonferroni post hoc analysis to compare
groups of three or more. Unless otherwise stated, means ± SEM
are shown and N refers to the number of animals analyzed. Statis-
tical significance was set at p < 0.05.
Study Approval
Animal procedures were approved by the BCH IACUC.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article on-
line at https://doi.org/10.1016/j.stemcr.2017.11.015.
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